Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report

RATIONALE: Aggressive variant of splenic marginal zone lymphoma (AV-SMZL) is a very rare disease that is often associated with TP53 mutations and has a poor prognosis. On the other hand, recent advances in genome sequencing techniques enable us to understand the molecular characteristics of rare can...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishiguro, Kazuya, Sasaki, Yasushi, Takagi, Yoshitake, Niinuma, Takeshi, Suzuki, Hiromu, Tokino, Takashi, Hayashi, Toshiaki, Takahashi, Tohru, Igarashi, Tetsuyuki, Matsuno, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458248/
https://www.ncbi.nlm.nih.gov/pubmed/32871937
http://dx.doi.org/10.1097/MD.0000000000021938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458248/
https://www.ncbi.nlm.nih.gov/pubmed/32871937
http://dx.doi.org/10.1097/MD.0000000000021938

Ejemplares similares